Suppr超能文献

抑制长链非编码 RNA HOTAIR 通过调控 miR-126/EGFL7 轴减轻 RCC 血管生成。

Suppression of lncRNA HOTAIR alleviates RCC angiogenesis through regulating miR-126/EGFL7 axis.

机构信息

Department of Pathology, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, Zhengzhou, People's Republic of China.

Department of Urology, Henan Provincial People's Hospital, Zhengzhou, People's Republic of China.

出版信息

Am J Physiol Cell Physiol. 2021 May 1;320(5):C880-C891. doi: 10.1152/ajpcell.00459.2019. Epub 2021 Jan 27.

Abstract

Renal cell carcinoma (RCC) has the highest mortality rate among urological cancers and tumor angiogenesis that plays a critical role in RCC progress. Epidermal growth factor-like domain multiple 7 (EGFL7) has been recently identified as a regulator in RCC tumor angiogenesis and progression. Long noncoding RNA (LncRNA) HOTAIR has been considered as a pro-oncogene in multiple cancers, but its precise mechanism of tumor angiogenesis has rarely been reported. MicroRNA-126 (miR-126) functions as a tumor suppressor in RCC. However, the underlying tumor angiogenesis mechanism of HOTAIR/miR-126 axis in RCC has not been studied. The proliferation, migration, angiogenesis, and expression of EGFL7 and related proteins in extracellular signal-regulated kinase (ERK)/activators of transcription 3 (STAT3) signal pathway were determined to examine the effect and mechanism of HOTAIR and miR-126 on RCC progress. The regulatory relationship of HOTAIR and miR-126, as well as miR-126 and EGFL7 were tested using dual-luciferase reporter assay. Aenograft RCC mice model was used to examine the effect of HOTAIR on RCC tumor growth and metastasis in vivo. HOTAIR knockdown and miR-126 overexpression suppressed the proliferation, migration, and angiogenesis of RCC cells. HOTAIR regulated EGFL7 expression by competitively binding to miR-126. Knockdown of HOTAIR significantly suppressed the RCC tumor progression and lung metastasis in vivo. These findings suggest that lncRNA HOTAIR regulate RCC angiogenesis through miR-126/EGFL7 axis and provide a new perspective on the molecular pathways of angiogenesis in RCC development, which might be potential therapeutic targets for RCC treatment.

摘要

肾细胞癌(RCC)是泌尿系统癌症中死亡率最高的癌症,肿瘤血管生成在 RCC 的进展中起着关键作用。表皮生长因子样结构域 7(EGFL7)最近被鉴定为 RCC 肿瘤血管生成和进展的调节剂。长链非编码 RNA(LncRNA)HOTAIR 被认为是多种癌症中的原癌基因,但它在肿瘤血管生成中的精确机制很少有报道。miR-126 在 RCC 中作为肿瘤抑制因子发挥作用。然而,HOTAIR/miR-126 轴在 RCC 中对肿瘤血管生成的潜在机制尚未研究。通过测定细胞外信号调节激酶(ERK)/转录激活因子 3(STAT3)信号通路中 EGFL7 及其相关蛋白的增殖、迁移、血管生成和表达,研究了 HOTAIR 和 miR-126 对 RCC 进展的影响及其机制。通过双荧光素酶报告基因检测试验检测 HOTAIR 和 miR-126 以及 miR-126 和 EGFL7 的调控关系。使用 Aenograft RCC 小鼠模型在体内检测 HOTAIR 对 RCC 肿瘤生长和转移的影响。HOTAIR 敲低和 miR-126 过表达抑制了 RCC 细胞的增殖、迁移和血管生成。HOTAIR 通过竞争性结合 miR-126 调节 EGFL7 的表达。HOTAIR 敲低显著抑制了 RCC 肿瘤在体内的进展和肺转移。这些发现表明,lncRNA HOTAIR 通过 miR-126/EGFL7 轴调节 RCC 血管生成,并为 RCC 发展中血管生成的分子途径提供了新的视角,可能成为 RCC 治疗的潜在治疗靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验